Effect of 5% dextrose epidural injections in reducing chronic low back pain

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201028049175N5

Enrollment

150

Registered

2021-03-01

Start date

2021-04-04

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back pain. Dorsalgia, unspecified

Interventions

Intervention 1: Intervention group:In first group (Dextrose) 10 cc of 5% Dextrose will be injected to epidural space in 0,7,15,30 days. Intervention 2: Intervention group:In second group (local anesth

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Moderate to severe low back pain (5 or more in VAS(Visual Analogue Scale)) for at least 6 months. Able to seating position Do not response to common treatment Patients with 20-75 years old

Exclusion criteria

Exclusion criteria: Progressive weakness Recent bladder or intestinal dysfunction Local infection Unstable psychological disorders Other chronic pains such as pain of upper extremities Anticoagulation state Pregnancy Indication of surgery Underlying disease such as cardiovascular, renal or severe pulmonary disorders

Design outcomes

Primary

Measure	Time frame
Patients pain score. Timepoint: In recovery (15 minutes after injection), 2,4,12,24 and 48 hours after injections and after last injection every week till one month and then every month for three months. Method of measurement: VAS (Visual Analogue Scale).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com086-32222003-8

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026